Daryl Faulkner, Bruce Huebner, Alan Guttmacher, Francis Collins | GenomeWeb
Osmetech has named Daryl Faulkner to be non-executive chairman. The company’s current chairman, Gordon Hall, will step down but will remain on the board as a non-executive director.
 
Faulkner recently was president and CEO of Digene, and he was a senior vice president and general manager for strategic business and international operations at Invitrogen.
 
Osmetech also said that Bruce Huebner has retired from the company and has left his position as a director.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.